Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration.
作者信息
Varkonyi Judit, Karádi István, Szocs Katalin, Sugár István, Sápi Zoltán, Marschalko Márta, Pállinger Eva, Darvas Zsuzsanna, Falus András
出版信息
Acta Oncol. 2008;47(3):458-61. doi: 10.1080/02841860701491066. Epub 2007 Jul 3.
PMID:17851872
Abstract
摘要
相似文献
1
Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration.
Acta Oncol. 2008;47(3):458-61. doi: 10.1080/02841860701491066. Epub 2007 Jul 3.
2
[Plasmacytic skin infiltration in multiple myeloma].
Orv Hetil. 2008 May 11;149(19):877-81. doi: 10.1556/OH.2008.28165.
3
Signet-ring plasma cell myeloma.
Am J Hematol. 2012 Jun;87(6):625. doi: 10.1002/ajh.22155. Epub 2011 Sep 26.
4
[Multiple myeloma with cutaneous involvement in a patient with long-standing MGUS].
Sangre (Barc). 1993 Apr;38(2):156-7.
5
[Initial central nervous system involvement in a case of non-secretory multiple myeloma].
Sangre (Barc). 1993 Oct;38(5):389-91.
6
CD138 shedding in plasma cell myeloma.
Br J Haematol. 2010 Aug;150(3):249. doi: 10.1111/j.1365-2141.2010.08203.x. Epub 2010 Apr 23.
7
Neoplasms of terminally differentiated B lymphocytes.
Clin Lab Med. 1988 Mar;8(1):197-210.
8
Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
Anticancer Res. 2007 Jan-Feb;27(1B):571-4.
9
Bone marrow plasma cell infiltration in multiple myeloma.
Br J Haematol. 1984 Jun;57(2):351-3.
10
Temporal bone involvement in multiple myeloma.
Otol Neurotol. 2006 Jun;27(4):580-1. doi: 10.1097/01.mao.0000188349.44430.59.
Zotero 插件